Holger Moch
Impact in
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Pulmonary and Respiratory Medicine top 0.02%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Renal and related cancers 90
- Epigenetics and DNA Methylation 33
-
- Renal cell carcinoma treatment 115
- Co-authors
- Peter A. Humphrey (4 shared papers)Victor E. Reuter (10 shared papers)Thomas M. Ulbright (3 shared papers)Antonio L. Cubilla (2 shared papers)Guido Sauter (61 shared papers)Peter Schraml (101 shared papers)Michael J. Mihatsch (58 shared papers)Lukas Bubendorf (22 shared papers)
- Journals
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (31 papers)The American Journal of Surgical Pathology (23 papers)International Journal of Cancer (22 papers)Modern Pathology (17 papers)PLoS ONE (16 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Holger Moch
599 papers receiving 36.5k citations
Holger Moch's Hit Papers
Peers
Comparison fields: 5 of 184
- Cancer Research 7.9k
- Pulmonary and Respiratory Medicine 12.6k
- Oncology 9.1k
- Molecular Biology 14.8k
- Immunology 3.0k
Countries citing papers authored by Holger Moch
This map shows the geographic impact of Holger Moch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Moch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Moch more than expected).
Fields of papers citing papers by Holger Moch
This network shows the impact of papers produced by Holger Moch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Moch. The network helps show where Holger Moch may publish in the future.
Co-authors
The 25 scholars most cited alongside Holger Moch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 607 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours Hit paper breakdown → | 2016 | 2116 |
| 2 | Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients Hit paper breakdown → | 2000 | 1364 |
| 3 | The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours Hit paper breakdown → | 2016 | 1298 |
| 4 | The Heidelberg classification of renal cell tumours Hit paper breakdown → | 1997 | 1039 |
| 5 | The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia Hit paper breakdown → | 2013 | 745 |
| 6 | An Immune Atlas of Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2017 | 710 |
| 7 | Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL Hit paper breakdown → | 2003 | 696 |
| 8 | The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters Hit paper breakdown → | 2013 | 569 |
| 9 | The single-cell pathology landscape of breast cancer Hit paper breakdown → | 2020 | 552 |
| 10 | Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. | 1999 | 478 |
| 11 | The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours Hit paper breakdown → | 2022 | 441 |
| 12 | 2001 | 439 | |
| 13 | WHO Classification of Tumours of the Urinary System and Male Genital Organs Hit paper breakdown → | 2016 | 380 |
| 14 | 2001 | 372 | |
| 15 | 2006 | 331 | |
| 16 | 2010 | 328 | |
| 17 | 2007 | 320 | |
| 18 | Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney Hit paper breakdown → | 2009 | 312 |
| 19 | 2017 | 312 | |
| 20 | 1999 | 308 |
About Holger Moch
Holger Moch is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Surgery, having authored 607 papers that have together received 37.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (115 papers), Cancer Genomics and Diagnostics (110 papers), Renal and related cancers (90 papers), Bladder and Urothelial Cancer Treatments (40 papers), Cancer, Hypoxia, and Metabolism (34 papers), Epigenetics and DNA Methylation (33 papers), Cancer Immunotherapy and Biomarkers (31 papers) and Immunotherapy and Immune Responses (28 papers). The work is most often cited by research in Cancer Research (7.9k citations), Pulmonary and Respiratory Medicine (12.6k citations), Oncology (9.1k citations), Molecular Biology (14.8k citations) and Immunology (3.0k citations). Holger Moch has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Peter A. Humphrey, Victor E. Reuter, Thomas M. Ulbright, Antonio L. Cubilla, Guido Sauter, Peter Schraml, Michael J. Mihatsch, Lukas Bubendorf, Thomas C. Gasser and Wilhelm Krek. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, The American Journal of Surgical Pathology, International Journal of Cancer, Modern Pathology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.